SRXH - srxhealth.com Market Value to Book Value Ratio

srxhealth.com - graphic logo of issuer SRXH

The efficiency of SRx Health Solutions Inc. (SRXH) relies on the sales volumes of rare drugs in Canada, and the company's market valuation chart on GURU.Markets helps track the impact of government tariffs on this process. The business is based on an extensive network of clinics and pharmacies with its own logistics hub. A service-based medication delivery model ensures a steady cash flow, with the current metric standing at 0.14.

srxhealth.com (SRXH) Market Capitalization to Net Assets: for the period 05/01/2025 - 10/29/2026
Flagship merchandise of SRx Health Solutions Inc.

The management expertise of SRx Health Solutions Inc. (SRXH) in pharmaceutical logistics creates high added value for its assets. This market-to-book premium ratio measures the gap between the exchange price and the net value of capital. A value exceeding one confirms market confidence in the business's intangible advantages. Stable dynamics in the market-to-book premium ratio signal fundamental resilience; however, extreme peaks on the chart warn of the risk of asset overvaluation.

Competitor analysis

VRTX: Market Capitalization to Book Value Ratio|alnylam.com - Market Value to Book Value|Market Value to Book Value Ratio Insmed|United Therapeutics Corp (UTHR) - Market Capitalization to Book Value|Market Value to Book Value Ratio BioMarin Pharma (BMRN)|BBIO: Market Capitalization to Net Assets|Market Capitalization to Book Value Ratio BGM (BGM Group)|cogentbio.com (COGT) - Market-to-Book Ratio|Xeris Biopharma Holdings - Market Capitalization to Book Value Ratio|Keros Therapeutics Inc (KROS) - Market Cap to Net Assets Ratio|ARCT: Market Capitalization to Book Value Ratio|ETON - Market Capitalization to Book Value|KMDA (Kamada Ltd.) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio fulcrumtx.com|Market Value to Book Value Ratio Abeona Therapeutics (ABEO)|Market Value to Book Value Ratio MREO (mereobiopharma.com)|Market Capitalization to Book Value Ratio PLX (Protalix)|Market Capitalization to Book Value Pliant Therapeutics Inc (PLRX)|APLT: Market Cap to Net Assets Ratio|Market Capitalization to Net Assets RNTX|GELS: Market Capitalization to Book Value Ratio|Market-to-Book Ratio Aytu BioPharma (AYTU)|CMMB (Chemomab Therapeutics Ltd) - Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio PLRZ (Polyrizon Ltd.)|Market Cap to Net Assets Ratio AEZS (Aeterna Zentaris)|CYTH (cyclotherapeutics.com) - Market Value to Book Value|Market Value to Book Value Ratio Inozyme Pharma INZY|RPHM (Reneo Pharmaceuticals Inc.) - Market Capitalization to Net Assets|Aeterna Zentaris - Market Capitalization to Book Value Ratio